EHP Funds Inc’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

EHP Funds Inc’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-70,000	Closed	-$2.69M	–	321
2023 Q2	$2.69M	Buy	+70,000	New	+$1.8M	0.66%	31

EHP Funds Inc's KDNY Position: Q3 2023 in Review

EHP Funds Inc sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 70,000 shares — an estimated $2.69M sold.

EHP Funds Inc first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $2.69M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

EHP Funds Inc reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
EHP Funds Inc sold 70,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.69M.
EHP Funds Inc first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
EHP Funds Inc's Chinook Therapeutics, Inc. Common Stock position peaked at $2.69M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on EHP Funds Inc's 13F filing for Q3 2023, filed 14 Nov 2023.